Unknown

Dataset Information

0

RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals.


ABSTRACT: Activation of the melanocortin-4 receptor (MC4R) with the synthetic agonist RM-493 decreases body weight and increases energy expenditure (EE) in nonhuman primates. The effects of MC4R agonists on EE in humans have not been examined to date.In a randomized, double-blind, placebo-controlled, crossover study, we examined the effects of the MC4R agonist RM-493 on resting energy expenditure (REE) in obese subjects in an inpatient setting.Twelve healthy adults (6 men and 6 women) with body mass index of 35.7 ± 2.9 kg/m(2) (mean ± SD) received RM-493 (1 mg/24 h) or placebo by continuous subcutaneous infusion over 72 hours, followed immediately by crossover to the alternate treatment. All subjects received a weight-maintenance diet (50% carbohydrate, 30% fat, and 20% protein) and performed 30 minutes of standardized exercise daily. Continuous EE was measured on the third treatment day in a room calorimeter, and REE in the fasting state was defined as the mean of 2 30-minute resting periods.RM-493 increased REE vs placebo by 6.4% (95% confidence interval, 0.68-13.02%), on average by 111 kcal/24 h (95% confidence interval, 15-207 kcal, P = .03). Total daily EE trended higher, whereas the thermic effect of a test meal and exercise EE did not differ significantly. The 23-hour nonexercise respiratory quotient was lower during RM-493 treatment (0.833 ± 0.021 vs 0.848 ± 0.022, P = .02). No adverse effect on heart rate or blood pressure was observed.Short-term administration of the MC4R agonist RM-493 increases REE and shifts substrate oxidation to fat in obese individuals.

SUBMITTER: Chen KY 

PROVIDER: S-EPMC4399297 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals.

Chen Kong Y KY   Muniyappa Ranganath R   Abel Brent S BS   Mullins Katherine P KP   Staker Pamela P   Brychta Robert J RJ   Zhao Xiongce X   Ring Michael M   Psota Tricia L TL   Cone Roger D RD   Panaro Brandon L BL   Gottesdiener Keith M KM   Van der Ploeg Lex H T LH   Reitman Marc L ML   Skarulis Monica C MC  

The Journal of clinical endocrinology and metabolism 20150212 4


<h4>Context</h4>Activation of the melanocortin-4 receptor (MC4R) with the synthetic agonist RM-493 decreases body weight and increases energy expenditure (EE) in nonhuman primates. The effects of MC4R agonists on EE in humans have not been examined to date.<h4>Objective, design, and setting</h4>In a randomized, double-blind, placebo-controlled, crossover study, we examined the effects of the MC4R agonist RM-493 on resting energy expenditure (REE) in obese subjects in an inpatient setting.<h4>Stu  ...[more]

Similar Datasets

| S-EPMC6374207 | biostudies-literature
| S-EPMC5641599 | biostudies-literature
| S-EPMC8070728 | biostudies-literature
| S-EPMC7263790 | biostudies-literature
| S-EPMC3410277 | biostudies-literature
| S-EPMC6463894 | biostudies-literature
| S-EPMC7582737 | biostudies-literature
| S-EPMC6935811 | biostudies-literature
| S-EPMC5418562 | biostudies-literature
| S-EPMC4008720 | biostudies-literature